Abstract
The use of anti-tumour necrosis factor alpha
(anti-TNFα) therapies has increased over the
past few years. Concerns have been raised
about the theoretical increased risk of malignancy
in patients receiving these therapies.
We report a case of an extremely rare high
grade pleural based sarcoma in a patient with
rheumatoid arthritis and a 7-year history of
anti-TNFα therapy.
(anti-TNFα) therapies has increased over the
past few years. Concerns have been raised
about the theoretical increased risk of malignancy
in patients receiving these therapies.
We report a case of an extremely rare high
grade pleural based sarcoma in a patient with
rheumatoid arthritis and a 7-year history of
anti-TNFα therapy.
| Original language | English |
|---|---|
| Pages (from-to) | e13 |
| Number of pages | 2 |
| Journal | Rheumatology Reports |
| Volume | 3 |
| DOIs | |
| Publication status | Published - 13 Oct 2011 |